US regulators recommend 'pause' in use of J&J vaccine over blood clot fears

Washington (AFP) – US health authorities recommended a “pause” Tuesday in the use of the Johnson & Johnson Covid-19 vaccine “out of an abundance of caution” over potential links to a rare type of blood clot, in a blow to the country’s immunization campaign. The disorder appears similar to that observed in rare cases of people who received the AstraZeneca vaccine in Europe — and the shots by both companies are based on adenovirus vector technology. The US Food and Drug Administration and the Centers for Disease Control are assessing the “potential significance” of six reported cases of a type …

Read More

HEDGE accordingly